Search results
PROMOTED
Author(s):
Nicolas M Van Mieghem
,
Kendra J Grubb
,
David Hildick-Smith
,
et al
Start date:
Mar 26, 2024
PROMOTED
Start date:
Apr 08, 2024
End date:
Apr 08, 2024
At14:30 CET (08:30 EST) on Monday 8 April, in Room 2 at EHRA 2024 in Berlin, DE, Radcliffe Education is hosting a CME-accredited symposium entitled 'Advanced Approaches to Combined Epicardial and Endocardial Strategies – From New Consensus to Practice’.Under the expert moderation ofDr Hugh Calkins (Baltimore, US) and Prof Riyaz Kaba (London, UK) a leading international faculty comprising Prof…
View more
Start date:
Oct 16, 2020
End date:
Oct 17, 2020
Mayo Clinic is committed to taking care of our patients, learners and staff. Due to the COVID-19 pandemic, Mayo Clinic Department of Cardiovascular Medicine education is suspending live courses and conferences through December 31, 2020. Please continue to check our website as we shift to meeting our learner needs by providing virtual and on-demand offerings. We will continue to closely monitor…
View more
Author(s):
Frank Provenier
,
Steven Droogmans
Added:
3 years ago
Atrial fibrillation (AF) is defined as a supraventricular tachycardia with rapid uncoordinated atrial activation, beat-to-beat irregularity and frequently rapid ventricular rate.2 It is the most frequently observed sustained arrhythmia in clinical practice.3 An estimated 12 million individuals in the EU and 2.3–10 million in the US have AF, and these numbers are expected to increase as the age of…
View more
Author(s):
Paul Kalra
Added:
10 months ago
ESC-HFA 23 – Prof Paul Kalra (Portsmouth Hospitals NHS Trust, UK) joins us onsite to discuss the IRONMAN trial (NCT02642562).
The IRONMAN trial aimed to study the effectiveness of intravenous iron in patients with heart failure and iron deficiency when compared to standard care. It showed that administration of IV FDI led to lower rates of recurrent heart failure hospitalisations and…
View more
Author(s):
Sanghamitra Mohanty
,
Andrea Natale
Added:
2 years ago
Author(s):
Stephen J Greene
Added:
10 months ago
ESC-HFA 23 — Dr Stephen Greene (Duke University School of Medicine, US) outlines the findings from the QoL study of the TRANSFORM-HF Trial (NCT03296813).
The TRANSFORM-HF trial is a randomized trial which compared torsemide to furosemide as a treatment for patients with heart failure. Around 2859 patients with heart failure were enrolled in the trial, whose clinical outcomes were measured across…
View more
Added:
3 years ago
Source:
Radcliffe News Team
Vienna, Austria – 27 May 2018: Playing video games that involve physical exertion (known as exergaming) improves quality of life in patients with heart failure, according to late breaking results from the HF-Wii study presented today at Heart Failure 2018 and the World Congress on Acute Heart Failure, a European Society of Cardiology congress.1
Professor Tiny Jaarsma, principal investigator of…
View more
Author(s):
Milind Y Desai
Added:
2 years ago
In this short summary interview, Dr Milind Desai (Cleveland Clinic, US) discusses the SPIRIT-HCM trial. The study assessed changes in exercise capacity and quality of life after septal myectomy in patient with hypertrophic cardiomyopathy.
Discussion Points
Background for the Trial
Study Design and Patient Population
Key Findings
Take-Home Messages
Next Steps
Recorded remotely from Cleveland…
View more